{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:40:38Z","timestamp":1790023238564,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.revmed.2010.04.004","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T09:13:32Z","timestamp":1274951612000},"page":"540-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Myopathies inflammatoires et anticorps anti-PM-Scl\u00a0: \u00e0 propos d\u2019une s\u00e9rie et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"31","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lahaxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-B.","family":"Duval-Modeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2010.04.004_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI108616","article-title":"Antinuclear antibody with distinct specificity for polymyositis","volume":"59","author":"Wolfe","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2010.04.004_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","article-title":"Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome","volume":"4","author":"Brouwer","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.revmed.2010.04.004_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.20056","article-title":"PM-Sc-75\u00a0is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome","volume":"50","author":"Raijmakers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/art.1780310409","article-title":"Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)","volume":"31","author":"Reimer","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.173.4.941","article-title":"Molecular characterization of an autoantigen of PM-Scl in the polymyositis\/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex","volume":"173","author":"Alderuccio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2010.04.004_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2010.04.004_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2010.04.004_bib9","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1186\/ar1729","article-title":"Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2010.04.004_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1990.tb01445.x","article-title":"Autoantibodies to nucleolar antigens in systemic sclerosis: clinical correlations","volume":"123","author":"Blaszczyk","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2340\/0001555571312316","article-title":"Clinical, serologic, and immunogenetic studies in patients with dermatomyositis","volume":"71","author":"Duncan","year":"1991","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.revmed.2010.04.004_bib12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2133.1996.d01-1052.x","article-title":"Childhood sclerodermatomyositis: report of a case with the anti-PM-Scl antibody and mechanic's hands","volume":"135","author":"Garcia-Patis","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","article-title":"Immunogenetic associations of scleroderma-related antinuclear antibodies","volume":"33","author":"Genth","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","article-title":"Clinical implications of autoantibody screening in patients with autoimmune myositis","volume":"39","author":"Ghirardello","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.revmed.2010.04.004_bib15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflamamtory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib16","first-page":"155","article-title":"Principaux anticorps antinucl\u00e9aires et anticytoplasmiques au cours des polymyosites et des dermatomyosites. \u00c9tude de 42\u00a0observations","volume":"16","author":"Meyer","year":"1987","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2010.04.004_bib17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/art.1780271011","article-title":"Multiplicity of antibodies in myositis sera","volume":"27","author":"Reichlin","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00915286","article-title":"Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes","volume":"4","author":"Reichlin","year":"1984","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2010.04.004_bib19","first-page":"1729","article-title":"Anti-PM\/Scl autoantibodies in patients without clinical polymyositis or scleroderma","volume":"23","author":"Schnitz","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib20","first-page":"356","article-title":"PM-Scl autoantibody positive scleroderma with polymyositis (mechanic's hand: clinical aid in the diagnosis","volume":"18","author":"T\u00f6r\u00f6k","year":"2004","journal-title":"JEADV"},{"key":"10.1016\/j.revmed.2010.04.004_bib21","first-page":"658","article-title":"Clinical relevance of PM-1\u00a0antibody and physiochemical characterization of PM-1\u00a0antigen","volume":"11","author":"Treadwell","year":"1984","journal-title":"J Rheumatol Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib22","first-page":"129","article-title":"Anti-PM\/Scl antibodies in connective tissue disease: clinical and biological assessment of 14\u00a0patients","volume":"24","author":"Vandergheynst","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib23","first-page":"2169","article-title":"Patients with antibodies to both PmScl and dsDNA","volume":"31","author":"Warner","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2010.04.004_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2010.04.004_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.revmed.2005.02.002","article-title":"Les nouveaux crit\u00e8res diagnostiques et d\u2019\u00e9valuation des polymyosites et des dermatomyosites","volume":"26","author":"Ch\u00e9rin","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2010.04.004_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.revmed.2006.05.015","article-title":"Auto-anticorps anti-PM-Scl. \u00c9tude de pr\u00e9valence et de signification","volume":"27","author":"Gaudin","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2010.04.004_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100\u00a0French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2010.04.004_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O\u2019Callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2010.04.004_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162\u00a0cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2010.04.004_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib33","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2010.04.004_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis, a computer-assisted analysis of ninety-two cases","volume":"28","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer-assisted analysis of 153\u00a0patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2010.04.004_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/brain\/98.4.637","article-title":"Polymyositis: its presentation, morbidity and mortality","volume":"98","author":"De Vere","year":"1975","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2010.04.004_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1982.tb03087.x","article-title":"Polymyositis \u2013 treatment and prognosis: a study of 107\u00a0patients","volume":"65","author":"Henriksson","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2010.04.004_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0301-0082(90)90026-D","article-title":"Polymyositis and dermatomyositis 1990 \u2013diagnosis, treatment and prognosis","volume":"35","author":"Henriksson","year":"1990","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.revmed.2010.04.004_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75\u00a0patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2010.04.004_bib41","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2010.04.004_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","article-title":"Factors affecting survivorship in polymyositis: a life-table study of 124\u00a0patients","volume":"14","author":"Medsger","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2010.04.004_bib43","doi-asserted-by":"crossref","unstructured":"Selva-O\u2019Callaghan A, Mijares-Boechk-Behrens T, Labrador-Horrillos M, Solans-Laque R, Grau-Junyent JM, Vilardeli-Tarres M. Anti-PM-Scl antibodies in a patient with inclusion body myositis. Rheumatology (Oxford) 2003;42:1016","DOI":"10.1093\/rheumatology\/keg253"},{"key":"10.1016\/j.revmed.2010.04.004_bib44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2010.04.004_bib45","doi-asserted-by":"crossref","unstructured":"Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, et al., Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody. Br J Dermatol 2010;162:337\u201344.","DOI":"10.1111\/j.1365-2133.2009.09484.x"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310005746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866310005746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:26:27Z","timestamp":1759335987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866310005746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0248866310005746"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2010.04.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myopathies inflammatoires et anticorps anti-PM-Scl\u00a0: \u00e0 propos d\u2019une s\u00e9rie et revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2010.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}